Effect of Shen Tao Ruangan Pill for Postoperative Recurred Liver Cancer
- VernacularTitle:参桃软肝丸对术后复发性肝癌的治疗作用
- Author:
Zhanhua LIU
;
Haifu HUANG
- Publication Type:Journal Article
- Keywords:
LIVER NEOPLASMS /TCD therapy;
SHEN TAO RUANGAN PILL/therapeutic use
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2004;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】To investigate the therapeutic effect of Shen Tao Ruangan Pill(STRP) for postoperative recurred liver cancer by a randomized and controlled trial.【Methods】Forty patients with postoperative recurred liver cancer were equally randomized into groups A and B.The two groups received routine symptomatic treatment,and group A was additionally treated with STRP(mainly composed of Herba Artemisiae Scopariae,Herba Hedyotis Diffusae,Herba Scutellariae Barbatae,Rhizoma Curcumae,Semen Persicae,Radix Angelicae Sinensis,Radix Salviae Miltiorrhizae,Radix Ginseng,Poria,Carapax et Plastrum Testudinis) and group B with Pingxiao Capsule.After 3-month treatment,the therapeutic effect was evaluated in the two groups.【Results】(1)After treatment,the symptoms were relieved in both of groups A and B,and group A had a better effect in relieving abdominal distention,anorexia and lassitude than group B(P0.05).(3) The non-progressive survival period was(172?11.64) days in group A and(143?10.95) days in group B;the survival rate within 3,6 and 10 months was 82.31%,70.42% and 50.33% in group A respectively,and 72.70%,65.70% and 46.33% in group B respectively;the median survival time was(203?20.87) days in group A and(167?19.58) days in group B,the difference being significant(P
